• 1445 Citations
  • 8 Scopus h-Index
20002020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Nabeel Aslam is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 22 Similar Profiles
Peritoneal Dialysis Medicine & Life Sciences
Kidney Medicine & Life Sciences
Acute Kidney Injury Medicine & Life Sciences
Nephrotic Syndrome Medicine & Life Sciences
Proteinuria Medicine & Life Sciences
Membranous Glomerulonephritis Medicine & Life Sciences
Critical Illness Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2020

An Open-Label Pilot Study of Adrenocorticotrophic Hormone in the Treatment of IgA Nephropathy at High Risk of Progression

Zand, L., Canetta, P., Lafayette, R., Aslam, N., Jan, N., Sethi, S. & Fervenza, F. C., Jan 2020, In : Kidney International Reports. 5, 1, p. 58-65 8 p.

Research output: Contribution to journalArticle

Open Access
Adrenocorticotropic Hormone
Immunoglobulin A
Glomerular Filtration Rate
Therapeutics
Proteins

Ambulatory Blood Pressure Monitoring: Profiles in Chronic Kidney Disease Patients and Utility in Management

Aslam, N., Missick, S. & Haley, W. E., Mar 1 2019, In : Advances in Chronic Kidney Disease. 26, 2, p. 92-98 7 p.

Research output: Contribution to journalReview article

Ambulatory Monitoring
Ambulatory Blood Pressure Monitoring
Chronic Renal Insufficiency
Blood Pressure
Masked Hypertension

A novel variant in FN1 in a family with fibronectin glomerulopathy

Aslam, N., Singh, A., Cortese, C. & Riegert-Johnson, D. L., Dec 1 2019, In : Human Genome Variation. 6, 1, 11.

Research output: Contribution to journalArticle

Open Access
Fibronectins
Exome
Deposits
Genes
Mutation
12 Citations (Scopus)

Rituximab or cyclosporine in the treatment of membranous nephropathy

Fervenza, F. C., Appel, G. B., Barbour, S. J., Rovin, B. H., Lafayette, R. A., Aslam, N., Jefferson, J. A., Gipson, P. E., Rizk, D. V., Sedor, J. R., Simon, J. F., Mccarthy, E. T., Brenchley, P., Sethi, S., Avila-casado, C., Beanlands, H., Lieske, J. C., Philibert, D., Li, T., Thomas, L. F. & 18 others, Green, D. F., Juncos, L. A., Beara-lasic, L., Blumenthal, S. S., Sussman, A. N., Erickson, S. B., Hladunewich, M., Canetta, P. A., Hebert, L. A., Leung, N., Radhakrishnan, J., Reich, H. N., Parikh, S. V., Gipson, D. S., Lee, D. K., Da Costa, B. R., Jüni, P. & Cattran, D. C., Jul 4 2019, In : New England Journal of Medicine. 381, 1, p. 36-46 11 p.

Research output: Contribution to journalArticle

Membranous Glomerulonephritis
Cyclosporine
Proteinuria
Phospholipase A2 Receptors
Therapeutics
1 Citation (Scopus)

Behçet's syndrome and focal segmental glomerulosclerosis with nephrotic syndrome - Successful treatment with etanercept

Leonard, D., Cortese, C., Wadei, H. M., Porter, I. & Aslam, N., May 1 2018, In : Clinical Nephrology. 89, 5, p. 371-375 5 p.

Research output: Contribution to journalArticle

Focal Segmental Glomerulosclerosis
Nephrotic Syndrome
Kidney
Aphthous Stomatitis
Therapeutics